SARY DE LA ROSA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHARLOTTE, NC NPI 1932670197

General Payments — all program years on this page

$3,390.18

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 148
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $836.53 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $836.5339

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $845.4437
2022 $818.7338
2023 $889.4834
2024 $836.5339

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086934717 Novartis Pharmaceuticals Corporation $23.09 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086934719 Novartis Pharmaceuticals Corporation $24.79 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086934727 Novartis Pharmaceuticals Corporation $16.94 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104478830 AstraZeneca Pharmaceuticals LP $15.50 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104479756 AstraZeneca Pharmaceuticals LP $14.36 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105602632 AstraZeneca Pharmaceuticals LP $19.94 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105617785 AstraZeneca Pharmaceuticals LP $21.04 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291397 Regeneron Healthcare Solutions, Inc. $26.45 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291399 Regeneron Healthcare Solutions, Inc. $30.54 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291401 Regeneron Healthcare Solutions, Inc. $28.43 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291403 Regeneron Healthcare Solutions, Inc. $27.11 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291405 Regeneron Healthcare Solutions, Inc. $19.97 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114291407 Regeneron Healthcare Solutions, Inc. $18.41 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115897166 GlaxoSmithKline, LLC. $18.35 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116002309 GlaxoSmithKline, LLC. $15.10 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116260348 GlaxoSmithKline, LLC. $15.46 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116263941 GlaxoSmithKline, LLC. $16.56 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116265130 GlaxoSmithKline, LLC. $27.30 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116458201 GlaxoSmithKline, LLC. $20.72 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116466760 GlaxoSmithKline, LLC. $7.39 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116594254 GlaxoSmithKline, LLC. $14.42 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116698051 GlaxoSmithKline, LLC. $12.00 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126634475 kaleo, Inc. $24.91 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126634477 kaleo, Inc. $16.69 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133186193 Genentech USA, Inc. $19.27 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133186198 Genentech USA, Inc. $19.69 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957113 GENZYME CORPORATION $27.30 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957115 GENZYME CORPORATION $15.01 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957117 GENZYME CORPORATION $23.87 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957133 GENZYME CORPORATION $30.47 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957141 GENZYME CORPORATION $25.39 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957143 GENZYME CORPORATION $22.19 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957171 GENZYME CORPORATION $23.42 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957173 GENZYME CORPORATION $38.96 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957187 GENZYME CORPORATION $4.60 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957305 GENZYME CORPORATION $24.08 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957309 GENZYME CORPORATION $9.04 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957313 GENZYME CORPORATION $36.38 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139957349 GENZYME CORPORATION $41.39 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.